MicroPort CardioFlow Medtech Corporation provided consolidated revenue guidance for the year ended December 31, 2023. The group is expected to record a revenue of RMB 330 million to RMB 340 million for the year ended December 31, 2023, representing an increase of approximately 31% to 36% as compared to RMB 251 million for the year ended December 31, 2022.